Why the study?
Does antilipolytic treatment with a nicotinic acid analogue improve exercise tolerance and reduce exercise-induced ST segment depression in men with stable angina pectoris?
Does antilipolytic treatment with a nicotinic acid analogue improve exercise tolerance and reduce exercise-induced ST segment depression in men with stable angina pectoris?
Antilipolytic therapy with a nicotinic acid analogue significantly reduces exercise-induced ST segment depression in men with stable angina, likely by shifting myocardial metabolism toward glucose oxidation.
Answers are grounded in this paper and cite their sources.
Reduces ischemic ECG changes without improving time to angina in stable CAD; extends metabolic modulation data but questions symptom-focused benefits.
A double-blind cross-over study was performed on 12 men sith stable angina pectoris in order to determine the effect of antilipolytic treatment on exercise tolerance and exercise-induced electrocardiographic changes. The men were exercised to the onset of anginal pain using a reproducible and standardized ergometric load. A nicotinic acid analogue was used to reduce plasma free fatty acids and free glycerol before and during exercise testing and to eliminate their post-exercise rise. This was associated with significant reduction of exercise-induced ST segment depression (p less than 0-005), though there was no significant difference in the duration of exercise before the oneset of pain. A change in the prportions of lipid and carbohydrate for oxidation by the ischaemic myocardium, making relatively more glucose available, is a likely explanation.
No takes yet. Share an insight, caveat, or question.
Luxton et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: